These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 8605764)

  • 21. Enhancement of power Doppler signals from breast lesions with the ultrasound contrast agent EchoGen emulsion: subjective and quantitative assessment.
    Albrecht T; Patel N; Cosgrove DO; Jayaram V; Blomley MJ; Eckersley R
    Acad Radiol; 1998 Apr; 5 Suppl 1():S195-8; discussion S199. PubMed ID: 9561080
    [No Abstract]   [Full Text] [Related]  

  • 22. Perflenapent emulsion (EchoGen): a new long-acting phase-shift agent for contrast echocardiography.
    Grayburn P
    Clin Cardiol; 1997 Oct; 20(10 Suppl 1):I12-8. PubMed ID: 9383597
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blood contrast enhancement with a novel, non-gaseous nanoparticle contrast agent.
    Wickline SA; Hughes M; Ngo FC; Hall CS; Marsh JN; Brown PA; Allen JS; McLean MD; Scott MJ; Fuhrhop RW; Lanza GM
    Acad Radiol; 2002 Aug; 9 Suppl 2():S290-3. PubMed ID: 12188251
    [No Abstract]   [Full Text] [Related]  

  • 24. Ultrasound contrast enhancement of tumours.
    Cosgrove D
    Clin Radiol; 1996 Feb; 51 Suppl 1():44-9. PubMed ID: 8605772
    [No Abstract]   [Full Text] [Related]  

  • 25. Assessment of brain perfusion with echo contrast specific imaging modes and Optison.
    Hölscher T; Postert T; Meves S; Thies T; Ermert H; Bogdahn U; Wilkening W
    Acad Radiol; 2002 Aug; 9 Suppl 2():S386-8. PubMed ID: 12188285
    [No Abstract]   [Full Text] [Related]  

  • 26. Sonochemically produced fluorocarbon microspheres: a new class of magnetic resonance imaging agent.
    Webb AG; Wong M; Kolbeck KJ; Magin R; Suslick KS
    J Magn Reson Imaging; 1996; 6(4):675-83. PubMed ID: 8835962
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 3D-power Doppler ultrasound of breast lesions with a microbubble contrast agent.
    Krestan CR; Riedl C; Memarsadeghi M; Rudas M; Pfarl G; Helbich TH
    Acad Radiol; 2002 Aug; 9 Suppl 2():S384-5. PubMed ID: 12188284
    [No Abstract]   [Full Text] [Related]  

  • 28. [Microbubbles for the kidney].
    Claudon M; Lefevre F
    J Radiol; 1999 Jun; 80(6):547. PubMed ID: 10417881
    [No Abstract]   [Full Text] [Related]  

  • 29. [Technique for ultrasound imaging with contrast media using nonlinearity and time variance].
    Wilkening W; Lazenby J; Ermert H
    Biomed Tech (Berl); 1998; 43 Suppl():18-9. PubMed ID: 9859236
    [No Abstract]   [Full Text] [Related]  

  • 30. Perflenapent emulsion: a US contrast agent for diagnostic radiology--multicenter, double-blind comparison with a placebo. EchoGen Contrast Ultrasound Study Group.
    Robbin ML; Eisenfeld AJ
    Radiology; 1998 Jun; 207(3):717-22. PubMed ID: 9609895
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Liver blood flow measurements using radioactive colloids.
    Tothill P; McLoughlin GP; Macpherson AI
    Br J Radiol; 1971 May; 44(521):403. PubMed ID: 5574708
    [No Abstract]   [Full Text] [Related]  

  • 32. Safety assessment of the use of perflenapent emulsion for contrast enhancement of echocardiography and diagnostic radiology ultrasound studies.
    Quay SC; Eisenfeld AJ
    Clin Cardiol; 1997 Oct; 20(10 Suppl 1):I19-26. PubMed ID: 9383598
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Microbubble echo-enhancers: a new direction for ultrasound?
    Blomley M; Cosgrove D
    Lancet; 1997 Jun; 349(9069):1855-6. PubMed ID: 9217754
    [No Abstract]   [Full Text] [Related]  

  • 34. Diagnostic ultrasound-induced membrane damage in phagocytic cells loaded with contrast agent and its relation to Doppler-mode images.
    Miller DL; Quddus J
    IEEE Trans Ultrason Ferroelectr Freq Control; 2002 Aug; 49(8):1094-102. PubMed ID: 12201456
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Physical and acoustical properties of perfluorooctylbromide, an ultrasound contrast agent.
    André M; Nelson T; Mattrey R
    Invest Radiol; 1990 Sep; 25(9):983-7. PubMed ID: 2211056
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blood-pool echo enhancement after intravenous injection of galactose-based microbubbles: results from European phase III clinical trials in Doppler sonography.
    Schlief R; Schürmann R; Niendorf HP
    Acad Radiol; 1996 Aug; 3 Suppl 2():S466-7. PubMed ID: 8796631
    [No Abstract]   [Full Text] [Related]  

  • 37. Lysis and sonoporation of epidermoid and phagocytic monolayer cells by diagnostic ultrasound activation of contrast agent gas bodies.
    Miller DL; Quddus J
    Ultrasound Med Biol; 2001 Aug; 27(8):1107-13. PubMed ID: 11527597
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The potential clinical impact of perflubron emulsion on general sonography.
    Mattrey RF
    Invest Radiol; 1991 Nov; 26 Suppl 1():S186-7; discussion S198-200. PubMed ID: 1808123
    [No Abstract]   [Full Text] [Related]  

  • 39. Gas emulsions as ultrasound contrast agents. Preliminary results in rabbits and dogs.
    Mattrey RF; Wrigley R; Steinbach GC; Schutt EG; Evitts DP
    Invest Radiol; 1994 Jun; 29 Suppl 2():S139-41. PubMed ID: 7928210
    [No Abstract]   [Full Text] [Related]  

  • 40. Use of intravenous Optison contrast echocardiography reduces downstream resource use and enhances cost savings.
    Shaw LJ; Dittrich HC
    Acad Radiol; 1998 Apr; 5 Suppl 1():S250-1; discussion S252-3. PubMed ID: 9561093
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.